Latest Research Collaboration News

Invex Therapeutics reports a net loss of $715,582 for H1 2026 while advancing its Exenatide program targeting neurological diseases, alongside notable board reshuffles.

Noxopharm Limited has secured a major scientific milestone with the publication of its Sofra™ platform research in Nature Immunology, highlighting a novel anti-inflammatory mechanism with broad therapeutic potential.

HITIQ has made significant strides in expanding its concussion management technology, PROTEQT©, into North America and Australian retail, backed by strong research partnerships and a successful capital raise.

PainChek has achieved FDA regulatory clearance enabling its device to qualify for US Remote Therapeutic Monitoring reimbursement, positioning the company for significant growth in the expanding US healthcare market. The company also reports strong global licence growth and a solid pipeline across multiple regions.

Battery Age Minerals has completed maiden drilling programs in Austria and Argentina, secured full ownership of its Canadian lithium project, and raised A$5.5 million to fuel its 2026 exploration ambitions.

Australasian Metals Limited has reported promising exploration results at its May Queen gold and bauxite projects, alongside strategic reviews of lithium assets and a solid cash position heading into 2026.

Strategic Energy Resources has completed key diamond drilling programs at Isa North and Canobie projects, revealing potential IOCG mineralisation and advancing its copper-gold portfolio with the acquisition of the Diamantina Project from Anglo American.

Strategic Elements Ltd reports steady progress in its cutting-edge ventures across automation, AI, and material science, supported by a strong cash position and government-backed innovation incentives.

A small-cap healthcare rally had a clear centre: distribution deals, US regulatory steps, and big cheques. Osteopore, Echo IQ and Anteris led the week, while a handful of names slipped despite solid operational updates.

Invex Therapeutics reports promising new data from its collaboration with Tessara Therapeutics on Exenatide’s potential in Alzheimer’s disease, alongside significant board changes and a solid cash position at quarter’s end.

BlinkLab Limited has secured independent scientific validation for its smartphone-based autism diagnostic technology through publication in the prestigious journal Autism Research, marking a significant milestone ahead of its FDA regulatory trial.

Mount Ridley Mines has entered a Material Transfer Agreement with Lawrence Livermore National Laboratory to explore rare earth element processing, marking a strategic move in critical minerals downstream development.